NOW APPROVED
THE PLAN IS
IN THE SCAN
Pixclara® (18F-FET) is the first and only FDA-approved amino acid PET imaging agent indicated to differentiate recurrent or progressive glioma from treatment-related change, in conjunction with other diagnostic evaluations, in adults and pediatric patients 1 month of age and older.1
NOW APPROVED
THE PLAN IS IN THE SCAN
Pixclara® (18F-FET) is the first and only FDA-approved amino acid PET imaging agent indicated to differentiate recurrent or progressive glioma from treatment-related change, in conjunction with other diagnostic evaluations, in adults and pediatric patients 1 month of age and older.1
Want to know if Pixclara® is available in your area?
Contact Telix Support
Phone: (463) 235-2159
Hours: Mon - Fri 8:00 AM - 5:00 PM ET.
Email: Telix Customer Service
Or complete the form below
Be the first to hear more about Pixclara®
All fields are required unless otherwise noted.
18F-FET, 18F-fluoro-ethyl-tyrosine; FDA, US Food and Drug Administration; PET, positron emission tomography.